Clinical Trial Update: The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the effect of empagliflozin on oxidative stress in patients with Type 2 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Henrik Enghusen Poulsen | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED